Capital Analysts LLC Trims Stock Position in Zoetis Inc. $ZTS

Capital Analysts LLC lessened its position in shares of Zoetis Inc. (NYSE:ZTS - Free Report) by 99.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 787 shares of the company's stock after selling 81,991 shares during the period. Capital Analysts LLC's holdings in Zoetis were worth $56,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently bought and sold shares of ZTS. Brighton Jones LLC grew its position in Zoetis by 180.4% during the fourth quarter. Brighton Jones LLC now owns 4,629 shares of the company's stock worth $754,000 after buying an additional 2,978 shares in the last quarter. Empowered Funds LLC raised its holdings in shares of Zoetis by 6.2% in the 1st quarter. Empowered Funds LLC now owns 11,293 shares of the company's stock valued at $1,859,000 after acquiring an additional 657 shares in the last quarter. Intech Investment Management LLC boosted its position in shares of Zoetis by 17.2% during the 1st quarter. Intech Investment Management LLC now owns 8,347 shares of the company's stock valued at $1,374,000 after acquiring an additional 1,224 shares during the last quarter. Sivia Capital Partners LLC boosted its position in shares of Zoetis by 73.8% during the 2nd quarter. Sivia Capital Partners LLC now owns 3,348 shares of the company's stock valued at $522,000 after acquiring an additional 1,422 shares during the last quarter. Finally, Glenview Trust co grew its holdings in shares of Zoetis by 11.8% during the second quarter. Glenview Trust co now owns 4,780 shares of the company's stock worth $745,000 after purchasing an additional 506 shares in the last quarter. 92.80% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on ZTS shares. Weiss Ratings cut shares of Zoetis from a "sell (d+)" rating to a "sell (d)" rating in a research report on Friday, June 12th. Argus reissued a "hold" rating on shares of Zoetis in a research note on Wednesday, May 27th. Piper Sandler decreased their price target on shares of Zoetis from $90.00 to $80.00 and set a "neutral" rating on the stock in a report on Monday, August 10th. Morgan Stanley set a $85.00 price objective on shares of Zoetis in a research report on Friday, August 7th. Finally, Barclays dropped their price objective on shares of Zoetis from $136.00 to $85.00 and set an "equal weight" rating for the company in a report on Wednesday, July 1st. Eight analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, Zoetis has a consensus rating of "Hold" and a consensus target price of $109.62.

Zoetis Stock Down 2.9%

Shares of ZTS opened at $73.64 on Friday. The firm has a market cap of $30.43 billion, a P/E ratio of 12.13, a P/E/G ratio of 1.28 and a beta of 0.74. The stock has a 50 day simple moving average of $76.30 and a two-hundred day simple moving average of $99.01. The company has a debt-to-equity ratio of 2.87, a current ratio of 3.08 and a quick ratio of 1.84. Zoetis Inc. has a 1 year low of $71.45 and a 1 year high of $160.48.

Zoetis (NYSE:ZTS - Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported $1.87 EPS for the quarter, topping the consensus estimate of $1.85 by $0.02. The firm had revenue of $2.47 billion for the quarter, compared to the consensus estimate of $2.50 billion. Zoetis had a net margin of 27.49% and a return on equity of 74.89%. The business's revenue was down .2% compared to the same quarter last year. During the same period last year, the firm posted $1.76 earnings per share. Zoetis has set its FY 2026 guidance at 6.150-6.250 EPS. On average, analysts forecast that Zoetis Inc. will post 6.19 earnings per share for the current fiscal year.

Zoetis Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 1st. Shareholders of record on Monday, July 20th will be paid a $0.53 dividend. The ex-dividend date of this dividend is Monday, July 20th. This represents a $2.12 annualized dividend and a yield of 2.9%. Zoetis's payout ratio is currently 34.93%.

About Zoetis

Zoetis Inc NYSE: ZTS is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company's offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source